Rothschild & Co Asset Management US’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$6.82M Buy
369,648
+154,713
+72% +$2.86M 0.1% 151
2022
Q3
$5.8M Sell
214,935
-1,535
-0.7% -$41.4K 0.1% 159
2022
Q2
$2.99M Sell
216,470
-5,938
-3% -$82.1K 0.05% 220
2022
Q1
$4.34M Sell
222,408
-66,716
-23% -$1.3M 0.06% 217
2021
Q4
$4.72M Sell
289,124
-15,148
-5% -$247K 0.06% 223
2021
Q3
$8.48M Sell
304,272
-40,759
-12% -$1.14M 0.11% 193
2021
Q2
$10.2M Sell
345,031
-38,797
-10% -$1.15M 0.12% 184
2021
Q1
$10.7M Sell
383,828
-46,008
-11% -$1.29M 0.13% 188
2020
Q4
$12.2M Sell
429,836
-8,485
-2% -$240K 0.16% 176
2020
Q3
$11M Sell
438,321
-45,255
-9% -$1.14M 0.2% 184
2020
Q2
$11.8M Buy
483,576
+3,209
+0.7% +$78.4K 0.17% 200
2020
Q1
$7.11M Sell
480,367
-79,397
-14% -$1.18M 0.11% 228
2019
Q4
$9.09M Buy
559,764
+524,707
+1,497% +$8.52M 0.09% 257
2019
Q3
$456K Buy
35,057
+7,636
+28% +$99.3K ﹤0.01% 340
2019
Q2
$356K Sell
27,421
-291
-1% -$3.78K ﹤0.01% 344
2019
Q1
$437K Sell
27,712
-21,729
-44% -$343K ﹤0.01% 354
2018
Q4
$995K Buy
49,441
+590
+1% +$11.9K 0.01% 352
2018
Q3
$1.21M Buy
48,851
+7,299
+18% +$181K 0.01% 354
2018
Q2
$1.14M Sell
41,552
-2,926
-7% -$80.3K 0.01% 354
2018
Q1
$1.37M Sell
44,478
-4,823
-10% -$149K 0.02% 334
2017
Q4
$1.76M Sell
49,301
-3,707
-7% -$133K 0.02% 325
2017
Q3
$1.46M Sell
53,008
-1,158
-2% -$31.9K 0.02% 317
2017
Q2
$1.43M Sell
54,166
-2,444
-4% -$64.5K 0.02% 351
2017
Q1
$1.18M Sell
56,610
-4,176
-7% -$86.8K 0.01% 359
2016
Q4
$1.26M Buy
60,786
+49,978
+462% +$1.03M 0.02% 373
2016
Q3
$175K Buy
10,808
+269
+3% +$4.36K ﹤0.01% 527
2016
Q2
$143K Buy
+10,539
New +$143K ﹤0.01% 557